Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Net Cash Flow (2016 - 2025)

InspireMD (NSPR) has 16 years of Net Cash Flow data on record, last reported at $51.8 million in Q3 2025.

  • For Q3 2025, Net Cash Flow rose 511.82% year-over-year to $51.8 million; the TTM value through Sep 2025 reached $47.4 million, up 398.43%, while the annual FY2024 figure was $9.2 million, 82.1% up from the prior year.
  • Net Cash Flow reached $51.8 million in Q3 2025 per NSPR's latest filing, up from -$874000.0 in the prior quarter.
  • Across five years, Net Cash Flow topped out at $51.8 million in Q3 2025 and bottomed at -$30.2 million in Q2 2023.
  • Average Net Cash Flow over 5 years is -$239368.4, with a median of -$1.1 million recorded in 2021.
  • Peak YoY movement for Net Cash Flow: soared 1434.03% in 2021, then plummeted 2565.59% in 2025.
  • A 5-year view of Net Cash Flow shows it stood at -$1.1 million in 2021, then skyrocketed by 165.19% to $691000.0 in 2022, then crashed by 709.7% to -$4.2 million in 2023, then skyrocketed by 172.51% to $3.1 million in 2024, then skyrocketed by 1597.02% to $51.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Cash Flow were $51.8 million in Q3 2025, -$874000.0 in Q2 2025, and -$6.6 million in Q1 2025.